Investigator Lenahan's approach appears to be rooted in thoroughness and compliance to set guidelines. He closely observes record keeping, data management systems, and communication among investigation team members. He is serious about label regulations and maintaining accuracy and validity in electronic data recording.

FDA Investigator Peter R Lenahan appears to focus on study monitoring and protocol compliance, clarity and adequacy of communication, data recording processes, and adherence to investigational drug packaging labeling regulations. He shows concern for transparency and effective communication between stakeholders. He is known for being meticulous in observing protocol compliance, maintaining high expectations for organizational records, and ensuring that investigational drugs are handled and labeled correctly.